DRUG · COUNSELLING NOTES
Avalglucosidase Alfa
Nexviazyme
Updated
New prescription
indication: _____. IV q2 weeks in clinic; report infusion reactions; warned on allergies; serious/common AEs: anaphylaxis, headache, fatigue; non-pharm: physiotherapy, energy conservation.
Refill prescription
refilled, adherence discussed, no SEs were reported
Dose change
Dose change discussed. new dose reviewed; IV q2 weeks in clinic; report infusion reactions; warned on allergies; serious/common AEs: anaphylaxis, headache, fatigue; non-pharm: physiotherapy, energy conservation.